Page contents Full notification Final report General information GMO characterization European Commission administrative Information Return to search

Full notification Final report - General information Notification Number B/DE/21/PEI4218 Member State to which the notification was sent Germany Date of acknowledgement from the Member State Competent Authority 26/08/2020 Title of the Project TIGER-CTL019 - Phase II trial of TisaGenlecleucel in Elderly Patients with First-Relapsed or Primary Refractory Agressive B-cell Non-Hodgkin Lymphoma Proposed period of release: 01/10/2020 to 31/12/2023 Name of the Institute(s) or Company(ies) Universitätsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik I.
Is the same GMO been notified elsewhere by the same notifier? No Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: Other Identity of the GMO: Autologous T cells transduced with a replication-deficient HIV-1 derived viral vector toexpress a chi- meric (murine/human) antigen receptor (CAR) Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Human Genus: Homo Species: Homo Sapiens Subspecies: Strain: Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Not known